MY assignment tonight is to talk about the way Of course, we understand that some anaesthein which chemistry and physics can help in the choice of compounds to be tested pharmacologically as candidate anaesthetics, and I shall illustrate this by reference to the work which led to the discovery of halothane (Fluothane). I shall suggest that of the properties which are wanted in an anaesthetic there are three which can be fairly closely related to chemical and physical properties. These are (1) absence of chemical toxicity, (2) absence of inflammability and explosive hazards, and (3) anaesthetic potency itself, and I shall show how one may attempt to design a molecule which will have these properties, and conclude with a general discussion of recent theories of relationships between molecular structure and anaesthetic potency, with especial reference to the work of Ferguson and of Mullins.
tists prefer to have each physiological response under the control of a separate drug.
It might be thought that since the biological processes involved in anaesthesia are so little understood, it would be impossible to rationalize the selection of compounds to test as anaesthetics. This is not so. Of course, it is quite impossible to assess from chemical and physical properties whether a compound will be a practical anaesthetic; far less could one hope to predict that a compound would be superior to those already in use. The verdict of the pharmacologist and of the anaesthetist himself cannot be anticipated; but although one cannot predict how a compound will show up in the all important finer points of anaesthesia, one may, by following the leads which are available, increase the chance of success by selecting the most profitable area of search.
Let us take first the question of toxicity. One way of reducing the risk that a compound will prove toxic is to work with compounds which are chemically inert and therefore unlikely to become involved in metabolic chemistry. One group of compounds which possesses a high degree of chemical stability is that of the fluorinated paraffins, in which chlorine and bromine may also be present. Table I shows the formulae of some of these compounds which are widely used as refrigerants TABLE I Some typical Arctons and in aerosols. When manufactured by I.C.I, they are known under the trade name, Arcton. The first two in the table, Arcton 4 and Arcton 6, are used as refrigerants. Arcton 6, Arcton 9 and Arcton 33 are used as propellants in aerosols. Paint, shaving soap, insecticide or perfume is packed under pressure with these low boiling compounds. When pressure is released through a simple valve the mixture is ejected usually as a fine spray, the Arcton evaporates, leaving the other ingredient behind. Also in the table is the formula of halothane. In passing we might note that the second carbon atom of halothane has bonds with four different atoms and halothane should therefore exist in two optically active isomers. The commercial product should be the racemic mixture, but we do not know how to resolve it into the dextro-and laevorotatory forms.
The Arcton compounds owe their use as refrigerants and in aerosols largely to their volatility, low toxicity and noninflammability, properties which are desirable in an anaesthetic inhalant. The first to suggest that the Arcton type of compound might be used as anaesthetics appear to have been Booth and Bixby (1932) who tested CFHCL and CFjHCl on mice. Both compounds produced convulsions. It is unfortunate that compounds of the Arcton type which are gases at room temperature frequently produce convulsions, as one might hope to find among these low boiling compounds, an anaesthetic of sufficient power to permit its use with adequate oxygen but weak enough to serve some of the purposes to which nitrous oxide is put.
In 1946 Robbins tested forty-two compounds on mice and, with the more promising, on dogs (Robbins, 1946) . He recommended four compounds for further tests but no clinical trials ensued. Robbins's results were of especial interest when examined in the light of Ferguson's (1939) work, as will later be described. They did not, however, suggest any particular compound not tested by Robbins as a potential practical anaesthetic.
I might mention here that one difficulty in assessing the reliability of reported tests of compounds as anaesthetics is doubt as to the degree of purity of the samples used, which is rarely indicated. One cannot be certain that when undesirable side effects are reported, they are due to the compound under test and not to some undetected impurity. But in the last few years very searching analytical techniques have come into use, notably the gas chromatograph and the mass spectrometer, and we would not consider a compound as suitable for test as an anaesthetic unless it were about 99.95 per cent pure.
Of course, application of these specialized techniques calls for the co-operation of specialists in analytical fields, and one cannot overstress the fact that the discovery and industrial development of even so simple a compound as halothane calls for the co-operation of very many skilled workers, chemists, engineers, physicists-quite apart from the work that is necessary on the biological side. The development of halothane has been very much a team effort.
We had at Widnes laboratory considerable experience in the specialized techniques for manufacturing the Arcton type of compound and in our desire to make further practical use of the special properties of these substances we decided to search among them and other fluorine containing compounds for an anaesthetic. Now the chemical inertness of these compounds is a consequence of the strong chemical bond between carbon and fluorine as a result of which the fluorine atom is extremely unreactive. The inertness of fluorine is especially pronounced in compounds containing the groups CF, -or CFj =, which are not only very stable themselves but also stabilize links between adjacent carbon atoms and halogen. Thus in halothane the CF 3 -group reduces the reactivity of the chlorine and bromine on the adjacent carbon atom. It seemed probable, therefore, that compounds containing the groups CF 3 -, or CF, = would, because of their high chemical stability be unlikely to interfere chemically with body metabolism. They should therefore have low toxicity.
So we hoped to minimize chemical toxicity by synthesizing very stable molecules. There is, of course, the other type of toxicity which is produced, like general anaesthesia, not by a chemical, but by a physical mechanism, when an excessive concentration of the compound in the body produces undesirable and sometimes irreversible toxic symptoms. The ratio of this toxic concen-tration to that concentration which produces satisfactory anaesthesia, which I believe you call margin of safety or anaesthetic index cannot be predicted. There is, however, evidence accumulating that, among compounds of the Arcton type, the margin of safety may be greater in polar compounds or in compounds containing hydrogen. By " polar compound " I mean a compound in which the distribution of electrons is asymmetrical, so that all parts of the molecule have not the same electrical charge. The possibility of electrostatic interaction with other molecules is then present.
We decided, in 1951, to concentrate in the first place on compounds containing the groups CF, -or CF 2 = to obtain stability and, we hoped, absence of chemical toxicity. As for making compounds which were noninflamable and nonexplosive, we knew that if we kept the percentage of hydrogen in the molecule low, this requirement would be met.
I should perhaps interpolate here a remark about the photochemical stability of halothane. As you may know, unstabilized halothane evolves bromine when exposed for some days to bright light. This evolution of bromine is completely prevented by addition to Fluothane, before sale, of 0.01 per cent w/w of thymol. The thymol acts by mopping up the free radicals produced by light, which would otherwise lead to bromine evolution by a chain reaction. As an added precaution Fluothane is stored in brown bottles, but the thymol itself gives adequate protection.
The remaining problem was the choosing of compounds with adequate anaesthetic potency. It might be thought that this would be a difficult matter, but, in fact, it is not, thanks principally to the work of Ferguson (1939 Ferguson ( , 1951 , who was responsible for initiating the search which led to the discovery of halothane. In this, his earlier work on the theory of narcosis proved of great value. I am using the term " narcosis " to denote the reversible inhibition of any biological function, Ferguson's contribution to the theory of narcosis, and therefore of anaesthesia, was to point out that the significance of data on narcosis is much greater when the concentrations of die drugs administered are expressed on a thermodynamic scale rather than in more usual ways, for example as percentages by volume.
Let us see how this works out. Table II shows results obtained by Meyer and Hemmi (1935) in experiments in which mice were anaesthetized by the compounds listed. The first column of figures gives the volume percentage of these compounds which were sufficient to produce anaesthesia. You will observe that the figures vary from 0.5 to 100 per cent, that is by a factor of 200. In the second column of figures the concentrations producing anaesthesia are expressed, as sugested by Ferguson, as relative saturations, that is to say, as the ratio of the partial pressure producing anaesthesia (p») to the saturated vapour pressure of the compound at the temperature of the experiment (p,). (This ratio, the relative saturation, when applied to water in the atmosphere gives the familiar relative humidity). You will notice that, when anaesthetic concentrations are expressed in this way, the range of the values is greatly reduced. In this case it is 0.01 to 0.07, a factor of 7, compared with a factor of 200 when volume percentages are used. The calculation of the ratio p»/pi should be clear from tables III and IV which give results with die Arcton type of compound in anaesthesia of mice. These tables include the saturated vapour pressure of the anaesthetic at 20 °C p, (either deter-termined experimentally or estimated from known vapour pressure curves of similar compounds) and the partial pressure for anaesthesia p» calculated from observed percentage by volume anaesthetic concentrations. The pressure at which the experiment is conducted is assumed to be 760 mm Hg, so that the partial pressure for anaesthesia equals anaesthetic concentration per cent by volume x 760 ~ 100. Variations from 20°C and 760 mm Hg likely to occur during normal atmospheric conditions would not affect significantly the values for p a /p, which are given to one significant figure only.
The ratio p^/p,, the relative saturation for anaesthesia, has a fundamental thermodynamic significance which I shall mention shortly, but first I shall give two more series of results in which anaesthetic concentrations are again expressed as gaseous volume percentages and also as relative saturations. The results in tables II and HI suggest the tentative hypothesis that any compound which is not chemically toxic will probably produce anaesthesia, if administered at a relative saturation of 0.03 to 0.08. Such generalizations are, however, not strictly true (Ferguson, 1951) and I shall comment on some striking exceptions later. Nevertheless, this generalization holds as a rough rule for a surprisingly large number of compounds of relatively low molecular weight. The higher the boiling point of a compound the lower will be its saturated vapour pressure at any temperature. So we can get a good idea of how potent a compound will be as an anaesthetic from its boiling point.
While on the subject of boiling point I might mention that we do bear in mind the fact that compounds boiling below about 30° C will have the practical disadvantage of necessitating storage in cylinders under pressure. On the other hand compounds with too high a boiling point may be excreted too slowly and delay recovery.
To return to the main theme. For one looking for an anaesthetic, the principal advantage to be gained from Ferguson's work is not that one can calculate in advance the approximate anaesthetic potency of a compound, useful though this is. It is, I think, that Ferguson's treatment shows that a very large part of the difference between the anaesthetic potencies of compounds when measured on the usual volume percentage scale is due to differences in saturated vapour pressure at the operative temperature. When these are allowed for, by expressing results as relative saturations, a much more uniform picture emerges, which shows, however, a previously unsuspected fine structure. Study of the residual differences which make up this fine structure can lead, in fact has led, to a much better understanding of the problem. Some otherwise obscure correlations are illuminated by Ferguson's concepts. For example, it had been argued that the chlorine atom possessed some peculiar power of confering anaesthetic potency on a compound, and it had been suggested that this might be due to some special effect in the brain. But Ferguson's work shows clearly that chloroform is a much more powerful anaesthetic than methane because its vapour pressure (p.) is always much lower than that of methane. Therefore, if anaesthesia is produced by both at the same relative saturation (p»/pi) a much lower partial pressure (p a ) of chloroform will suffice to produce anaesthesia than will be necessary with methane. Thus what was believed to be a peculiar property of the chlorine atom is brought into line with the behaviour of any group or atom which, when substituted for hydrogen in a molecule tends to raise the boiling point. Ferguson (1951) has made a preliminary exploration of the relation of chemical constitution to narcotic potency measured on the thermodynamic scale.
I have now told you of some of the chemical and physical background which we had to help us when we started the work which led to the discovery of halothane. Some of the compounds which we chose to test were chosen because they were readily available but halothane, which was at the time an unknown compound, was selected on the basis of the considerations which I have outlined and specially made for testing as an anaesthetic.
I should like in the short time left me to bring up to date the discussion of the relationships between physical properties and anaesthetic potency. First by saying a little more about Ferguson's work and then by alluding briefly to recent theories advanced by Mullins. I have time for no more than a very quick and therefore imprecise exposition. Those who wish to know more of the subject will find the papers by Ferguson and by Mullins (1954) well worth perusal.
Let us return first to the factor p»/p., which has a more fundamental significance than I have so far explained. The factor p./p, is approximately equal to the thermodynamic function known as " activity ". Thermodynamic activities are always referred to an arbitrary standard state to which unit activity is assigned. In this paper the pure liquid is taken as the standard state with unit thermodynamic activity.
It is a fundamental property of thermodynamic activity of a substance, one expression of which is, as I have explained, p a /p, the relative saturation, that it is equal in all phases in equilibrium. By equilibrium is meant a steady state in which the rate of loss of anaesthetic from the tissues is exactly balanced by the rate of uptake. It follows that, when an anaesthetic has become distributed in equilibrium between the inspired air and the body tissues, its thermodynamic activity will be p a /p. in all the body tissues. This helps to circumvent the difficulty, which often arises in biological work, that one can discuss the concentration of a drug only as it is in the ambient medium, in the inspired air for example, when one is most interested in concentrations in the tissues.
There is a major group of compounds which diverge from Ferguson's generalization in that they exhibit no anaesthetic power and no toxicity at any thermodynamic activity. These are the perfluoro compounds such as perfluoropentane. Mullins found that the saturated vapour of pentane C S H,, anaesthetized mice in 15 minutes, whereas the saturated vapour of C 5 F, 2 perfluoropentane, had no effect whatever after one hour. Similar observations have been' published by Banks, Campbell and Rudge (1954) .
An explanation for these facts is offered by Mullins (1954) . Mullins cc rrelates narcotic potency with the work required to replace a molecule in some biological tissue by a molecule of the narcotic. This work depends on the difference between the cohesive energy densities of the tissue and the narcotic. The cohesive energy density, as its name implies, is a measure of the forces holding a liquid together. Cohesive energy densities are dependent partly on molecular size which assumes great importance in Mullins's theories.
If two substances have very different cohesive energy densities, then much work will be required to replace a molecule of one by a molecule of the other. There will be a large heat of miving. When an anaesthetic and brain tissue form a solution which is far from ideal, the concentration of anaesthetic in both air and brain which is necessary to produce anaesthesia will be much higher than would be expected on the Ferguson basis. Perfluorocarbons have very low cohesive energy densities compared with those of brain tissues, and, even when the inspired air is saturated, enough perfluorocarbon to cause physiological activity is not transferred to the brain.
Mullins suggests that the cohesive energy densities of the brain tissue affected by anaesthesia is lower than that of body tissue in general. Therefore a good anaesthetic should have a cohesive energy density such that it is more readily taken up by the brain than by other organs. In an anaesthetic, like chloroform, which is liable to affect adversely some of the organs of the body, the cohesive energy density is too high and this permits it to be absorbed too readily in tissues other than the brain with consequent undesirable side effects. Mullins suggested that since the low cohesive energy densities of fluorocarbons lead to physiological inactivity perhaps some fluorochloroparafHn (that is Arcton type of compound) might have a suitable cohesive energy density for anaesthesia and still be stable and noninflammable. This suggestion was not made until after the discovery of halothane, although Mullins did not know of it.
I indicated earlier how the anaesthetic potency of a molecule seems to be markedly affected by its polarity. It is unfortunately not possible at present to calculate the effect of polar interactions on cohesive energy densities. We cannot tell whether polarity will be shown, eventually, to be another factor operating by modifying thermodynamic properties and so fit into the general picture, or whether the wheel will make a full turn in that polar interactions, and perhaps hydrogen bonding, will be found to have a specific effect in the production of anaesthesia.
You will have noticed that nothing has been said as to what is the mechanism by which anaesthetics produce anaesthesia. The theories which we have been discussing do not tell much about this, only that the mechanism must be thermodynamically reversible and physical. One may ask, what of the future? The discovery of halothane has led to a revived interest in the Arcton type of compound: many more of them will, no doubt, be tested. Whether as a result, new compounds will find their way into clinical practice remains to be seen. We may, at least, confidently hope that the work will contribute to a better understanding of the mechanism of anaesthesia.
